Finance

Beta
Lists
Q4 2026 earnings • released • EPS beat +2.95% • Revenue miss -4.35%
See results
EMAMILTD:NSE
Emami Ltd
₹413.90
-3.47%
(-14.90) 1D
May 21, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMAMILTD...
Open
₹431.95
High
₹438.00
Low
₹410.10
Mkt. cap
181.62B
Avg. vol.
434.28K
Volume
2.13M
Dividend
2.42%
Quarterly dividend
₹2.50
Ex-dividend date
Feb 10, 2026
P/E ratio
22.75
52-wk high
₹634.20
52-wk low
₹385.50
EPS
₹18.20
Shares outstanding
453.94M
No. of employees
3K
News stories
From sources across the web
Profile
Emami Group is an Indian multinational conglomerate headquartered in Kolkata. The company caters to a number of niche categories in the personal care and healthcare segments. The company's products are sold across 60+ nations and are available in 4.5 million retail outlets across India. The company has seven manufacturing units across India and one overseas unit. Among its prominent brands is an antiseptic cream named BoroPlus. The company's skin care division generated an overall revenue of ₹2,655 crores in the financial year 2019–20 with an annual profit of ₹639 crores. The total group revenue of the company stands at ₹20,000 crores. Wikipedia
About Emami Ltd
CEOSudhakar Rao Desai
Employees3.22K
Founded1974
Headquarters-
SectorPersonal care products
Websiteemamiltd.in
Last report
May 21, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹3.67 / ₹3.57
+2.95%beat
Revenue / Est. (INR)
9.25B / 9.67B
-4.35%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
9.63B
9.04B
7.99B
11.52B
Cost of goods sold
3.67B
2.76B
2.31B
3.38B
Cost of revenue
3.67B
2.76B
2.31B
3.38B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.13B
2.99B
2.78B
3.13B
Operating expense
4.13B
4.58B
4.34B
4.75B
Total operating expenses
7.80B
7.34B
6.65B
8.13B
Operating income
1.83B
1.70B
1.33B
3.39B
Other non operating income
-454.42M
215.90M
213.70M
189.70M
EBT including unusual items
1.94B
1.87B
1.50B
3.45B
EBT excluding unusual items
1.55B
1.87B
1.50B
3.55B
Income tax expense
315.28M
225.10M
18.30M
255.70M
Effective tax rate
16.28%
12.05%
1.22%
7.41%
Other operating expenses
568.97M
1.14B
1.11B
1.17B
Net income
1.62B
1.64B
1.48B
3.19B
Net profit margin
16.84%
18.17%
18.58%
27.74%
Earnings per share
4.16
4.22
3.92
7.54
Interest and investment income
212.75M
-
-
-
Interest expense
-27.77M
-24.30M
-26.30M
-29.20M
Net interest expenses
184.98M
-24.30M
-26.30M
-29.20M
Depreciation and amortization charges
207.80M
217.20M
222.30M
222.80M
EBITDA
2.23B
2.10B
1.74B
3.79B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer